• HLB Chessboard

Animal Ethics achieves investment from Dechra Pharmaceuticals

Updated: Jul 9, 2019



Animal Ethics has announced a licensing ageement and investment in the company by the the UK based Dechra Pharmaceuticals. Dechra has invested $18 million for a 33% stake in the company.

The full announcement by Dechra Pharmaceuticals can be accessed here.


​© Copyright 2015 HLB Chessboard Pty Ltd. All rights reserved. No portion of this website may be reproduced, copied, or in any way reused without written permission from HLB Chessboard Pty Ltd.

Liability limited by a scheme approved under Professional Standards Legislation.

ABN 41 164 223 394

AFSL 474103